Abstract
Chemokine receptor 5 (CCR5) is one of the two coreceptors that are utilized by the human immunodeficiency virus (HIV) to enter the cell. CCR5 inactivation is considered to be a promising approach to HIV therapy, including gene therapy. RNA interference provides a powerful tool to regulate gene expression and may be utilized to knockdown the CCR5 gene. Three artificial microRNAs (amiRNAs) directed to the human CCR5 gene were constructed, and their silencing activity was tested in indicator cells, which were derived from the HT1080 human cell line. A multiplexing of two or more amiRNAs in one transcript was shown to enhance the CCR5 gene silencing. A 95% reduction of CCR5 expression was achieved with the most efficient amiRNA combination.
Similar content being viewed by others
Abbreviations
- HIV:
-
human immunodeficiency virus
- amiRNA:
-
artificial microRNA
- miRNA:
-
microRNA
- shRNA:
-
short hairpin RNA
- siRNA:
-
short interfering RNA
References
Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382, 722–725.
Lucotte G. 2002. Frequencies of 32 base pair deletion of the (Delta 32) allele of the CCR5 HIV-1 co-receptor gene in Caucasians: A comparative analysis. Infect. Genet. Evol. 1, 201–205.
Biti R., Ffrench R., Young J., Bennetts B., Stewart G., Liang T. 1997. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature Med. 3, 252–253.
O’Brien S.J., Moore J.P. 2000. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol. Rev. 177, 99–111.
Zimmerman P.A., Buckler-White A., Alkhatib G., Spalding T., Kubofcik J., Combadiere C., Weissman D., Cohen O., Rubbert A., Lam G., Vaccarezza M., Kennedy P.E., Kumaraswami V., Giorgi J.V., Detels R., Hunter J., Chopek M., Berger E.A., Fauci A.S., Nutman T.B., Murphy P.M. 1997. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med. 3, 23–36.
Allers K., Hütter G., Hofmann J., Loddenkemper C., Rieger K., Thiel E., Schneider T. 2011. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. Blood. 117, 2791–2799.
Cannon P., June C. 2011. Chemokine receptor 5 knockout strategies. Curr. Opin. HIV AIDS. 6, 74–79.
Butticaz C., Ciuffi A., Muñoz M., Thomas J., Bridge A., Pebernard S., Iggo R., Meylan P., Telenti A. 2003. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antivir. Ther. 8, 373–377.
Shimizu S., Hong P., Arumugam B., Pokomo L., Boyer J., Koizumi N., Kittipongdaja P., Chen A., Bristol G., Galic Z., Zack J.A., Yang O., Chen I.S., Lee B., An D.S. 2010. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood. 115, 1534–1544.
An D.S., Qin F.X., Auyeung V.C., Mao S.H., Kung S.K. 2006. Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Mol. Ther. 14, 494–504.
Anderson J., Akkina R. 2007. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection. Gene Ther. 14, 1287–1297.
Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., Kay M.A. 2006. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature. 441, 537–541.
Castanotto D., Sakurai K., Lingeman R., Li H., Shively L., Aagaard L., Soifer H., Gatignol A., Riggs A., Rossi J., 2007. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res. 35, 5154–5164.
Scherr M., Eder M. 2007. Gene silencing by small regulatory RNAs in mammalian cells. Cell Cycle. 6, 444–449.
Makarova Yu.A., Krameriv D.A. 2007. Noncoding RNAs. Biochemistry (Moscow). 72(11), 1427–1448.
Sibley C.R., Seow Y., Wood M.J. 2010. Novel RNA-based strategies for therapeutic gene silencing. Mol. Ther. 18, 466–476.
McBride J., Boudreau R.L., Harper S.Q., Staber S.Q., Monteys A.M., Martins I., Gilmore B.L., Burstein H., Peluso R.W., Polisky B., Carter B., Davidson B.L. 2008. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl. Acad. Sci. U. S. A. 105, 5868–5873.
Boudreau R.L., Martins I., Davidson B.L. 2009. Artificial microRNAs as siRNA shuttles: Improved safety as compared to shRNAs in vitro and in vivo. Mol. Ther. 17(1), 169–175.
Nielsen T.T., Marion I., Hasholt L., Lundberg. C. 2009. Neuron-specific RNA interference using lentiviral vectors. J. Gene Med. 11, 559–569.
Shin K.J., Wall E.A., Zavzavadjian J.R., Santat L.A., Liu J., Hwang J., Rebres R., Roach T., Seaman W., Simon M., Fraser I. 2006. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc. Natl. Acad. Sci. U. S. A. 103, 13759–13864.
Liu Y.P., Haasnoot J., ter Brake O., Berkhout B., Konstantinova P. 2008. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res. 36, 2811–2824.
Aagaard L.A., Zhang J., von Eije K. J., Li H., Særom P., Amarzguioui M., Rossi J. 2008. Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs. Gene Ther. 115, 1536–1549.
Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheim-van Dillen P.M. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28, 495–503.
Kim S.S., Peer D., Kumar P., Subramanya S., Wu H., Asthana D., Habiro K., Yang C., Manjunath N., Shimaoka M., Shankar P. 2010. RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol. Ther. 18, 370–376
Mäkinen P.I., Koponen J.I., Kärkkäinen A.M., Malm T.M., Pulkkinen K.H., Koistinaho J., Turunen M.P., Ylä-Herttuala S. 2006. Stable RNA interference: Comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J. Gene Med. 8, 433–441.
Chung K.H., Hart C.C., Al-Bassam S., Avery A., Taylor J., Patel P. D., Vojtek A.B., Turner D.L. 2006. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res. 34(7), e53.
Sun D., Melegari M., Sridhar S., Rogler C.E., Zhu L. 2006. Multi-miRNA hairpin method that improves gene knockdown efficiency and provides linked multigene knockdown. Biotechniques. 41, 59–63.
McLaughlin J., Cheng D., Singer O., Lukacs R.U., Radu C.G., Verma I.M., Witte O.N. 2007. Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics. Proc. Natl. Acad. Sci. U. S. A. 104, 20501–20506.
Zhou H., Xia X.G., Xu Z. 2005. An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi. Nucleic Acids Res. 33(6), e62.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © D.V. Glazkova, A.S. Vetchinova, E.V. Bogoslovskaya, Y.A. Zhogina, M.L. Markelov, G.A. Shipulin, 2013, published in Molekulyarnaya Biologiya, 2013, Vol. 47, No. 3, pp. 475–485.
Rights and permissions
About this article
Cite this article
Glazkova, D.V., Vetchinova, A.S., Bogoslovskaya, E.V. et al. Downregulation of human CCR5 gene expression with artificial microRNAs. Mol Biol 47, 419–428 (2013). https://doi.org/10.1134/S0026893313030035
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893313030035